Alector, Inc. (ALEC)
USD 0.94
(-6.7%)
USD 0.94
(-6.7%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 487.66 Million USD | -14.92% |
| 2022 | 573.2 Million USD | 11.53% |
| 2021 | 513.93 Million USD | 132.84% |
| 2020 | 220.72 Million USD | -2.84% |
| 2019 | 227.17 Million USD | -44.01% |
| 2018 | 405.75 Million USD | 40.84% |
| 2017 | 288.09 Million USD | 264.59% |
| 2016 | 79.01 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 420.16 Million USD | -7.98% |
| 2024 Q1 | 456.58 Million USD | -6.37% |
| 2023 Q4 | 487.66 Million USD | -4.35% |
| 2023 FY | 487.66 Million USD | -14.92% |
| 2023 Q3 | 509.84 Million USD | -0.51% |
| 2023 Q2 | 512.43 Million USD | -9.36% |
| 2023 Q1 | 565.32 Million USD | -1.37% |
| 2022 FY | 573.2 Million USD | 11.53% |
| 2022 Q4 | 573.2 Million USD | -1.84% |
| 2022 Q3 | 583.93 Million USD | -2.86% |
| 2022 Q2 | 601.15 Million USD | -12.49% |
| 2022 Q1 | 686.92 Million USD | 33.66% |
| 2021 Q3 | 518.33 Million USD | 143.81% |
| 2021 Q2 | 212.59 Million USD | 0.03% |
| 2021 Q1 | 212.53 Million USD | -3.71% |
| 2021 Q4 | 513.93 Million USD | -0.85% |
| 2021 FY | 513.93 Million USD | 132.84% |
| 2020 Q3 | 221.39 Million USD | 2.17% |
| 2020 Q2 | 216.69 Million USD | -4.62% |
| 2020 FY | 220.72 Million USD | -2.84% |
| 2020 Q1 | 227.19 Million USD | 0.01% |
| 2020 Q4 | 220.72 Million USD | -0.31% |
| 2019 Q3 | 231.14 Million USD | -0.17% |
| 2019 Q2 | 231.53 Million USD | 0.73% |
| 2019 Q1 | 229.85 Million USD | -43.35% |
| 2019 FY | 227.17 Million USD | -44.01% |
| 2019 Q4 | 227.17 Million USD | -1.72% |
| 2018 Q1 | - USD | -100.0% |
| 2018 FY | 405.75 Million USD | 40.84% |
| 2018 Q4 | 405.75 Million USD | 1.06% |
| 2018 Q3 | 401.48 Million USD | 988.35% |
| 2018 Q2 | 36.88 Million USD | 0.0% |
| 2017 Q4 | 288.09 Million USD | 0.0% |
| 2017 FY | 288.09 Million USD | 264.59% |
| 2016 FY | 79.01 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 272.28 Million USD | -79.101% |
| Jaguar Health, Inc. | 45.86 Million USD | -963.247% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1189.72% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -4889.452% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 87.96% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -273.101% |
| ContextLogic Inc. | 206 Million USD | -136.733% |
| MiMedx Group, Inc. | 96.33 Million USD | -406.248% |
| MEI Pharma, Inc. | 8.35 Million USD | -5736.852% |
| AlloVir, Inc. | 45.01 Million USD | -983.348% |
| Novavax, Inc. | 2.57 Billion USD | 81.041% |
| Aptorum Group Limited | 5.25 Million USD | -9177.027% |
| Ardelyx, Inc. | 130.76 Million USD | -272.941% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -1.94% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -3928.758% |
| Vaxcyte, Inc. | 167.44 Million USD | -191.234% |
| Precigen, Inc. | 41.64 Million USD | -1071.043% |
| Pharming Group N.V. | 244.07 Million USD | -99.805% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -0.219% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -3990.497% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -234.32% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -281.615% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -13719.343% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -7280.784% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -7280.784% |
| Bicycle Therapeutics plc | 224.41 Million USD | -117.31% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -491.594% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -7241.096% |
| Acelyrin, Inc. | 86.35 Million USD | -464.739% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -3291.536% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -5044.73% |
| Senti Biosciences, Inc. | 52.57 Million USD | -827.639% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -609.058% |
| AbCellera Biologics Inc. | 335.77 Million USD | -45.236% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -24831.953% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -274.525% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -114.991% |
| Chimerix, Inc. | 19.74 Million USD | -2369.835% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -5106.245% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1580.748% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1286.325% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1170.865% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1322.522% |
| Alkermes plc | 933.53 Million USD | 47.761% |
| Fortress Biotech, Inc. | 165.93 Million USD | -193.884% |
| Fortress Biotech, Inc. | 165.93 Million USD | -193.884% |
| Agenus Inc. | 462.29 Million USD | -5.489% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -582.245% |
| Dyadic International, Inc. | 2.34 Million USD | -20734.759% |
| ImmuCell Corporation | 18.81 Million USD | -2491.913% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2898.641% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1627.73% |
| Lantern Pharma Inc. | 2.73 Million USD | -17700.205% |
| Immix Biopharma, Inc. | 3.72 Million USD | -13003.101% |
| Incyte Corporation | 1.59 Billion USD | 69.373% |
| IO Biotech, Inc. | 17.55 Million USD | -2677.791% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1252.457% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -13719.977% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -943.388% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -221.868% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -19845.562% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1672.633% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -107.33% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 1.383% |
| NextCure, Inc. | 14.99 Million USD | -3151.777% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -11965.042% |
| Onconetix, Inc. | 23.18 Million USD | -2003.755% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -7203.714% |
| Opthea Limited | 264.6 Million USD | -84.303% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1366.271% |
| PureTech Health plc | 125.58 Million USD | -288.324% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -915.512% |
| Seer, Inc. | 39.36 Million USD | -1138.839% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -37434.915% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -876.705% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -36414.087% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -5348.816% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -114.412% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -40.304% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -274.16% |
| ChromaDex Corporation | 26.5 Million USD | -1739.705% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -4368.288% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -572.026% |
| CRISPR Therapeutics AG | 346.76 Million USD | -40.633% |
| Precision BioSciences, Inc. | 140.92 Million USD | -246.061% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -253.896% |
| Innoviva, Inc. | 568.55 Million USD | 14.226% |
| Summit Therapeutics Inc. | 125.25 Million USD | -289.335% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -688.675% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1691.057% |
| ESSA Pharma Inc. | 3.49 Million USD | -13853.05% |
| GlycoMimetics, Inc. | 6.9 Million USD | -6965.543% |
| GT Biopharma, Inc. | 6.63 Million USD | -7252.163% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -84.451% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -480.379% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1694.946% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -15017.896% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -561.094% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2984.814% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -4317.417% |
| Soligenix, Inc. | 7.27 Million USD | -6603.442% |
| Century Therapeutics, Inc. | 175.94 Million USD | -177.178% |
| Kura Oncology, Inc. | 51.66 Million USD | -843.961% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -302.095% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -11699.395% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -7273.446% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -93.061% |
| Autolus Therapeutics plc | 263.9 Million USD | -84.788% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -4552.442% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -448.8% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -939.828% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -38.206% |
| GRI Bio, Inc. | 2.69 Million USD | -17981.906% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -60136.912% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1468.521% |
| IGM Biosciences, Inc. | 220.17 Million USD | -121.49% |
| INmune Bio, Inc. | 18.86 Million USD | -2485.458% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -90.14% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1730.465% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -17839.52% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -14766.752% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -734.264% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -407.149% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -84.21% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 40.747% |
| Verastem, Inc. | 71.18 Million USD | -585.073% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -891.681% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1164.112% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -896.626% |
| Histogen Inc. | 5.69 Million USD | -8460.102% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -11019.766% |
| Surrozen, Inc. | 8.14 Million USD | -5887.342% |
| Organovo Holdings, Inc. | 2.74 Million USD | -17646.325% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -155278.866% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -767.277% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -2853.422% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -854.286% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -58877.354% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -284.825% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -4409.779% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -223.197% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -18603.662% |
| Apollomics, Inc. | 14.15 Million USD | -3345.693% |
| Amarin Corporation plc | 279.58 Million USD | -74.425% |
| Mesoblast Limited | 188.79 Million USD | -158.302% |
| Turnstone Biologics Corp. | 14.14 Million USD | -3346.911% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -169.746% |
| Synaptogenix, Inc. | 5.52 Million USD | -8719.454% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -7235.575% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -186.682% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5598.937% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -27649.57% |
| Exelixis, Inc. | 678.44 Million USD | 28.12% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1945.42% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -197.276% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 17.93% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4466.102% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -29935.981% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1152.778% |
| Gritstone bio, Inc. | 125.91 Million USD | -287.288% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3222.901% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -9483.508% |
| Avid Bioservices, Inc. | 275.66 Million USD | -76.904% |
| Insmed Incorporated | 1.66 Billion USD | 70.653% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -6238.283% |
| MediWound Ltd. | 27.18 Million USD | -1693.758% |
| OmniAb, Inc. | 87.4 Million USD | -457.974% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -20.873% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -2546.779% |
| Zai Lab Limited | 240.17 Million USD | -103.046% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 22.599% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1568.556% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -412.92% |
| Immunic, Inc. | 25.36 Million USD | -1822.379% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -604.358% |
| Veracyte, Inc. | 93.71 Million USD | -420.352% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -18536.987% |
| FibroGen, Inc. | 585.72 Million USD | 16.741% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2705.436% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -74572.626% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -8522.98% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 93.631% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -5848.634% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -480.406% |
| TG Therapeutics, Inc. | 169.08 Million USD | -188.416% |
| Galecto, Inc. | 5.89 Million USD | -8171.184% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -5786.878% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 81.375% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1592.003% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -3763.949% |
| XBiotech Inc. | 8.39 Million USD | -5707.657% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3222.901% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -817.016% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -34.305% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1713.975% |
| Theravance Biopharma, Inc. | 169 Million USD | -188.555% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 59.882% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 2.549% |
| Vaxxinity, Inc. | 30.94 Million USD | -1475.973% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 49.853% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -7985.895% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 34.562% |
| NexImmune, Inc. | 5.08 Million USD | -9491.793% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -131207.722% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -15759.938% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 93.138% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -9361.897% |
| Scopus BioPharma Inc. | 7.45 Million USD | -6441.999% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1754.678% |
| Ainos, Inc. | 7.39 Million USD | -6495.27% |
| Pluri Inc. | 34.11 Million USD | -1329.611% |
| Prothena Corporation plc | 135.01 Million USD | -261.191% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -100.602% |
| Celularity Inc. | 102.92 Million USD | -373.792% |
| Rallybio Corporation | 9.43 Million USD | -5068.175% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1894.964% |
| MeiraGTx Holdings plc | 319.99 Million USD | -52.401% |
| Omeros Corporation | 403.25 Million USD | -20.934% |
| Humacyte, Inc. | 114.67 Million USD | -325.254% |
| Immunocore Holdings plc | 228.15 Million USD | -113.742% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -9903.467% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -535.482% |
| Blueprint Medicines Corporation | 918.64 Million USD | 46.914% |
| CalciMedica, Inc. | 4.02 Million USD | -12006.976% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -2694.344% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -216.374% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -468.266% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -75.551% |
| Pulmatrix, Inc. | 15.96 Million USD | -2954.996% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2991.796% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1881.911% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -94.439% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -860.243% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 59.718% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1434.371% |
| Nutriband Inc. | 1.07 Million USD | -45099.779% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -4486.373% |
| Vor Biopharma Inc. | 59.1 Million USD | -725.103% |
| Roivant Sciences Ltd. | 773.95 Million USD | 36.99% |
| Evogene Ltd. | 17.99 Million USD | -2610.778% |
| ProKidney Corp. | 29.21 Million USD | -1569.185% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -577.516% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -69074.576% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 74.183% |
| CorMedix Inc. | 11.91 Million USD | -3992.032% |
| BioLineRx Ltd. | 50.7 Million USD | -861.834% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -226.289% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -451.406% |
| Atai Life Sciences N.V. | 49.16 Million USD | -891.963% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1465.435% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -2615.004% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -291.275% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -8525.203% |
| MediciNova, Inc. | 3.89 Million USD | -12431.475% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -2567.919% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -32319.606% |
| GeoVax Labs, Inc. | 3.51 Million USD | -13754.701% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -22.758% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1489.016% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 82.082% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2955.187% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1462.992% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -731.008% |
| Absci Corporation | 58.3 Million USD | -736.425% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2460.211% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1421.019% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -560.888% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -457.444% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1344.089% |
| Allakos Inc. | 74.79 Million USD | -552.025% |
| Imunon, Inc. | 8.53 Million USD | -5616.818% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2067.321% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -324.754% |
| BioAtla, Inc. | 48.98 Million USD | -895.527% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4466.102% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -17448.363% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -273.395% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -3330.665% |
| XOMA Corporation | 145.58 Million USD | -234.984% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1348.593% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -609.244% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1443.403% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -688.815% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -984.552% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -907.539% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -16891.951% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -5877.788% |
| Akari Therapeutics, Plc | 4.58 Million USD | -10538.503% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2650.045% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 70.435% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -120637.643% |
| UroGen Pharma Ltd. | 243.52 Million USD | -100.256% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -51.881% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -17559.198% |
| Orgenesis Inc. | 35.53 Million USD | -1272.362% |
| Entera Bio Ltd. | 1.37 Million USD | -35263.959% |
| GH Research PLC | 6.7 Million USD | -7177.556% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -7071.603% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -2490.402% |
| Xencor, Inc. | 283.55 Million USD | -71.981% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -16233.626% |
| Replimune Group, Inc. | 113.21 Million USD | -330.75% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -12879.845% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -371.041% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -120637.643% |
| Portage Biotech Inc. | 4.45 Million USD | -10858.854% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -32319.606% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2015.701% |
| OncoCyte Corporation | 49.29 Million USD | -889.227% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -11688.542% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -61050.945% |
| Purple Biotech Ltd. | 10 Million USD | -4774.253% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -8328.431% |
| scPharmaceuticals Inc. | 57.26 Million USD | -751.66% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -3836.617% |
| HilleVax, Inc. | 78.9 Million USD | -518.014% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -9556.812% |
| Tharimmune, Inc. | 1.81 Million USD | -26768.134% |
| Genprex, Inc. | 3.25 Million USD | -14885.797% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1698.256% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -9213.77% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -236632.524% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -135912.194% |
| OKYO Pharma Limited | 7.42 Million USD | -6471.609% |
| Savara Inc. | 37.19 Million USD | -1211.22% |
| Curis, Inc. | 57.61 Million USD | -746.471% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1752.152% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1144.06% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -33672.091% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2242.423% |
| BeiGene, Ltd. | 2.23 Billion USD | 78.168% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2190.623% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -85.852% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2192.324% |
| Erasca, Inc. | 78.61 Million USD | -520.357% |
| bluebird bio, Inc. | 424.62 Million USD | -14.847% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -74324.649% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 74.198% |
| DBV Technologies S.A. | 42.8 Million USD | -1039.414% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -74324.649% |
| Moderna, Inc. | 4.57 Billion USD | 89.334% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -6871.68% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -29348.611% |
| Molecular Templates, Inc. | 31.17 Million USD | -1464.496% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -2756.878% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 17.078% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -291.686% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1677.414% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1237.692% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -776.551% |
| MacroGenics, Inc. | 154.2 Million USD | -216.243% |
| RenovoRx, Inc. | 4.46 Million USD | -10819.592% |
| Adicet Bio, Inc. | 37.12 Million USD | -1213.763% |
| Prime Medicine, Inc. | 60.78 Million USD | -702.351% |
| Aditxt, Inc. | 28.53 Million USD | -1609.227% |
| Adagene Inc. | 45.16 Million USD | -979.646% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -269776.204% |
| Quantum-Si incorporated | 26.63 Million USD | -1731.208% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 30.09% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -15928.889% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -324.204% |
| SciSparc Ltd. | 1.59 Million USD | -30474.859% |
| Vericel Corporation | 127.7 Million USD | -281.872% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -8663.312% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -471.321% |
| Generation Bio Co. | 171.63 Million USD | -184.14% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -4122.242% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1065.808% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -92.985% |
| Invivyd, Inc. | 51.71 Million USD | -843.03% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -430.208% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -7396.544% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -545.953% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -47663.859% |
| 2seventy bio, Inc. | 310.12 Million USD | -57.249% |
| ADMA Biologics, Inc. | 193.97 Million USD | -151.407% |
| Clene Inc. | 38.95 Million USD | -1152.006% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1249.655% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -89.772% |
| GeoVax Labs, Inc. | 3.51 Million USD | -13754.701% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -156.313% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -3903.962% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -145.898% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -3898.991% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -913.633% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -822.899% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -31.854% |
| Evaxion Biotech A/S | 17.61 Million USD | -2668.097% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -203.034% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -218.351% |
| Trevena, Inc. | 48.26 Million USD | -910.462% |
| Surrozen, Inc. | 8.14 Million USD | -5887.342% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2158.25% |
| Cingulate Inc. | 10.36 Million USD | -4606.837% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -17633.418% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1207.704% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -13497.275% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -3608.51% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -53.741% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1862.53% |
| Clearmind Medicine Inc. | 3.61 Million USD | -13408.807% |
| Kronos Bio, Inc. | 54.2 Million USD | -799.742% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -936.645% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2042.683% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -2329.719% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2050.552% |
| ImmunityBio, Inc. | 1.09 Billion USD | 55.276% |
| Korro Bio, Inc. | 51.75 Million USD | -842.319% |
| Kineta, Inc. | 7.22 Million USD | -6652.548% |
| BioVie Inc. | 9.7 Million USD | -4926.412% |
| Codexis, Inc. | 49.94 Million USD | -876.393% |
| Celularity Inc. | 102.92 Million USD | -373.792% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -406.685% |
| Celcuity Inc. | 51.45 Million USD | -847.849% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -141173.892% |
| Cibus, Inc. | 206.11 Million USD | -136.598% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1048.132% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1751.509% |
| IN8bio, Inc. | 8.77 Million USD | -5459.382% |
| Kodiak Sciences Inc. | 213.59 Million USD | -128.319% |
| Annexon, Inc. | 47.11 Million USD | -934.995% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -444.632% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -406.028% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -3462.488% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 81.268% |
| Eyenovia, Inc. | 19.78 Million USD | -2365.43% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -175.385% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -6249.03% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1923.607% |
| Arcellx, Inc. | 339.75 Million USD | -43.537% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -3998.748% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -98.611% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -4999.54% |
| Moolec Science SA | 13.94 Million USD | -3396.999% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1030.119% |
| Geron Corporation | 146.12 Million USD | -233.73% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -865.07% |
| Royalty Pharma plc | 6.29 Billion USD | 92.256% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1126.038% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -165545.062% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -19721.671% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -157.813% |
| Humacyte, Inc. | 114.67 Million USD | -325.254% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1578.665% |
| 89bio, Inc. | 59.96 Million USD | -713.283% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1742.833% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -40675.0% |
| Genelux Corporation | 8.42 Million USD | -5691.793% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -7013.025% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -257.741% |
| Notable Labs, Ltd. | 4.42 Million USD | -10915.789% |
| Liquidia Corporation | 73.13 Million USD | -566.779% |
| Mustang Bio, Inc. | 17.61 Million USD | -2667.859% |
| Immunovant, Inc. | 48.95 Million USD | -896.158% |
| Quantum-Si incorporated | 26.63 Million USD | -1731.208% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1170.534% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -15616.049% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -560.252% |
| Acasti Pharma Inc. | 11.55 Million USD | -4119.685% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2057.09% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -17839.52% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1222.42% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -35683.238% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -7899.82% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1863.636% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2003.472% |
| PepGen Inc. | 34.63 Million USD | -1308.186% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -3915.72% |
| United Therapeutics Corporation | 1.18 Billion USD | 58.749% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -6882.66% |
| Solid Biosciences Inc. | 38.45 Million USD | -1168.056% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5598.937% |
| Immuneering Corporation | 12 Million USD | -3961.081% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -155278.866% |
| Silo Pharma, Inc. | 1.56 Million USD | -30976.169% |
| Belite Bio, Inc | 4.21 Million USD | -11480.836% |
| XOMA Corporation | 145.58 Million USD | -234.984% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -19985.214% |
| Bionomics Limited | 10.15 Million USD | -4700.496% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2169.178% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2028.351% |
| uniQure N.V. | 624.01 Million USD | 21.85% |
| Cassava Sciences, Inc. | 14.19 Million USD | -3335.498% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -269776.204% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -186.554% |
| Forte Biosciences, Inc. | 3.66 Million USD | -13202.482% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -187045.363% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -7127.938% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -6249.03% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2705.436% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -4514.582% |
| Altimmune, Inc. | 16.54 Million USD | -2848.244% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 21.052% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2028.351% |
| Compugen Ltd. | 55.77 Million USD | -774.351% |
| Peak Bio, Inc. | 20.75 Million USD | -2249.831% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -341.477% |
| Benitec Biopharma Inc. | 4.96 Million USD | -9728.073% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -208.958% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -548.72% |
| Zura Bio Limited | 21.29 Million USD | -2190.386% |
| PolyPid Ltd. | 17.46 Million USD | -2691.785% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -333.873% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -548.72% |
| Instil Bio, Inc. | 99.8 Million USD | -388.641% |
| argenx SE | 444.95 Million USD | -9.601% |
| Immunome, Inc. | 28.65 Million USD | -1601.685% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -5749.454% |
| Verona Pharma plc | 58.84 Million USD | -728.791% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -3269.509% |
| Shattuck Labs, Inc. | 14.85 Million USD | -3181.977% |
| CervoMed Inc. | 2.59 Million USD | -18687.232% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -9905.519% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -3729.059% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -4529.037% |
| Moolec Science SA | 13.94 Million USD | -3396.999% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -20709.395% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -777.177% |
| AnaptysBio, Inc. | 364.28 Million USD | -33.87% |
| Design Therapeutics, Inc. | 11.95 Million USD | -3978.864% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -3744.757% |
| NeurAxis, Inc. | 1.91 Million USD | -25395.847% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1152.746% |
| Lumos Pharma, Inc. | 13.33 Million USD | -3557.609% |
| Achilles Therapeutics plc | 19.08 Million USD | -2454.98% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -3269.509% |
| 180 Life Sciences Corp. | 5.38 Million USD | -8952.35% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1967.446% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2042.683% |
| Nutriband Inc. | 1.07 Million USD | -45099.779% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1493.794% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -3260.685% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -21.53% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1401.768% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -3637.186% |
| Palisade Bio, Inc. | 2.73 Million USD | -17704.637% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -9183.628% |
| Beam Therapeutics Inc. | 478.38 Million USD | -1.941% |
| Neurogene Inc. | 36.54 Million USD | -1234.288% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -22.545% |
| AEON Biopharma, Inc. | 159.88 Million USD | -205.005% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -923.44% |
| Sesen Bio, Inc. | 30.98 Million USD | -1473.938% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1778.468% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -6314.827% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -149.144% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -153.919% |
| Athira Pharma, Inc. | 30.05 Million USD | -1522.481% |
| Vaccinex, Inc. | 5.94 Million USD | -8107.152% |
| HCW Biologics Inc. | 15.05 Million USD | -3139.907% |
| XOMA Corporation | 145.58 Million USD | -234.984% |
| Nektar Therapeutics | 267.04 Million USD | -82.616% |
| Arvinas, Inc. | 644.6 Million USD | 24.345% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2650.045% |
| Merus N.V. | 102.15 Million USD | -377.4% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -233.221% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -412.688% |
| Rezolute, Inc. | 11.73 Million USD | -4056.034% |
| Clene Inc. | 38.95 Million USD | -1152.006% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -17026.938% |
| BeyondSpring Inc. | 48.26 Million USD | -910.315% |
| Synlogic, Inc. | 32.89 Million USD | -1382.502% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -3237.227% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -29745.104% |
| Peak Bio, Inc. | 20.75 Million USD | -2249.831% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -668.479% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1127.952% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -29.477% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -389.78% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -112596.949% |
| MannKind Corporation | 721.36 Million USD | 32.396% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2083.43% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -23278.188% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -375.357% |
| Gossamer Bio, Inc. | 249.14 Million USD | -95.735% |
| CohBar, Inc. | 1.03 Million USD | -47079.864% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -4462.344% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2460.211% |
| Legend Biotech Corporation | 589.93 Million USD | 17.335% |
| Mural Oncology plc | 37.92 Million USD | -1185.776% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -267.675% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -21146.12% |
| Disc Medicine, Inc. | 22.87 Million USD | -2031.886% |
| Champions Oncology, Inc. | 28.03 Million USD | -1639.501% |
| REGENXBIO Inc. | 262.22 Million USD | -85.971% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -14416.758% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -3790.769% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -3530.752% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2199.783% |
| Vaxart, Inc. | 34.02 Million USD | -1333.267% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2291.793% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1609.207% |
| Cellectis S.A. | 249.57 Million USD | -95.4% |
| Longeveron Inc. | 5.33 Million USD | -9037.512% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1066.142% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 79.725% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -707.827% |
| Revolution Medicines, Inc. | 262.39 Million USD | -85.852% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -23045.183% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -5553.478% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -4032.438% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -3372.684% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -22571.734% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 90.53% |
| Denali Therapeutics Inc. | 122.96 Million USD | -296.598% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -8663.312% |
| Veru Inc. | 32.81 Million USD | -1386.22% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -6999.563% |
| Cingulate Inc. | 10.36 Million USD | -4606.837% |
| Passage Bio, Inc. | 39.26 Million USD | -1142.089% |
| Context Therapeutics Inc. | 4.19 Million USD | -11534.116% |
| Exicure, Inc. | 8.54 Million USD | -5604.398% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1552.667% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -4550.668% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2112.554% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -199.209% |
| Nuvalent, Inc. | 31.82 Million USD | -1432.442% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -7565.791% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -673.808% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -2609.272% |
| OmniAb, Inc. | 87.4 Million USD | -457.974% |
| Anew Medical, Inc. | 8.24 Million USD | -5817.021% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1173.65% |
| Lipocine Inc. | 2.63 Million USD | -18431.07% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1756.231% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1112.745% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1730.465% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -466.043% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -8929.235% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -489.349% |
| Ocugen, Inc. | 23.98 Million USD | -1933.394% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -950.852% |
| Q32 Bio Inc. | 233.12 Million USD | -109.185% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -5279.098% |
| Alumis Inc. Common Stock | 53.5 Million USD | -811.497% |
| Equillium, Inc. | 27.95 Million USD | -1644.354% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -136.054% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -8567.106% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -7851.599% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -209.974% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -602.359% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -4789.304% |
| Dominari Holdings Inc. | 4.63 Million USD | -10421.446% |
| Edesa Biotech, Inc. | 1.84 Million USD | -26380.191% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1549.369% |
| Bio-Techne Corporation | 744.34 Million USD | 34.483% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -286.735% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -41.577% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1101.895% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1584.114% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -428.009% |
| Nkarta, Inc. | 105.6 Million USD | -361.808% |
| BioCardia, Inc. | 4.59 Million USD | -10524.597% |
| Iterum Therapeutics plc | 32.66 Million USD | -1393.078% |